Domov › Diabetes mellitus 2. typu › Washington
Klinické štúdie Diabetes mellitus 2. typu v štáte Washington
20 štúdií pre Diabetes mellitus 2. typu hľadá účastníkov v zariadeniach v štáte Washington.
Mestá v štáte Washington
Oficiálny text štúdie (anglicky)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Universal Research Group, LLC, Tacoma
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07064473A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- ERA Health Research - Redmond, Redmond
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07754461A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Providence Regional Medical Center Everett, Everett
- University of Washington, Seattle
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 55 a viac · Všetky pohlavia · Aktualizované 28. 9. 2026 · NCT06112418Sleep Loss and Circadian Misalignment - Mechanisms of Insulin Resistance
- Sleep and Performance Research Center, Spokane
Prebieha náborFáza 4Vítaní zdravých dobrovoľníkov
Vek 18 až 45 · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT07494084A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Seattle
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 16. 9. 2026 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Era Health Research, Redmond
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Eastside Research Associates, Redmond
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT06897475A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- The Vancouver Clinic, Vancouver
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT07668388A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Renton
- Research Site, Seattle
- Research Site, Seattle
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07662213A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Seattle Children's Research Institute, Seattle
Prebieha náborFáza 3
Vek 10 až 18 · Všetky pohlavia · Aktualizované 9. 9. 2026 · NCT07282613A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Northwest Clinical Research Center, Bellevue
- Rainier Clinical Research Center, Renton
- Universal Research Group, Tacoma
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 8. 9. 2026 · NCT07215559A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Redmond
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 31. 8. 2026 · NCT07662109A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Renton
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 31. 8. 2026 · NCT07662044A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies
- Research Site, Renton
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 8. 2026 · NCT07606066A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Seattle Children's Hospital, Seattle
Prebieha náborFáza 3
Vek 10 až 17 · Všetky pohlavia · Aktualizované 7. 8. 2026 · NCT06739122A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
- Research Site, Renton
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 8. 2026 · NCT07664553ROME GS System Study
- Rainier Clinical Research Center, Renton
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 4. 2026 · NCT07518004Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes
- Seattle Children's Hospital, Seattle
- University of Washington Medicine Diabetes Institute, Seattle
Prebieha nábor
Vek 14 až 40 · Všetky pohlavia · Aktualizované 13. 6. 2025 · NCT06936670Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
- Seattle Children's Hospital, Seattle
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 8 až 14 · Všetky pohlavia · Aktualizované 24. 3. 2025 · NCT05008276Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes
- University of Washington - Harborview Medical Center, Seattle
Prebieha náborFáza 4
Vek 40 až 65 · Všetky pohlavia · Aktualizované 5. 6. 2024 · NCT05780905Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.